Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
04 2021
Historique:
received: 09 09 2020
revised: 12 02 2021
accepted: 14 02 2021
pubmed: 21 3 2021
medline: 25 8 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

To study whether the consumption of ultra-processed foods and drinks is associated with breast, colorectal, and prostate cancers. Multicentric population-based case-control study (MCC-Spain) conducted in 12 Spanish provinces. Participants were men and women between 20 and 85 years of age with diagnoses of colorectal (n = 1852), breast (n = 1486), or prostate cancer (n = 953), and population-based controls (n = 3543) frequency-matched by age, sex, and region. Dietary intake was collected using a validated food frequency questionnaire. Foods and drinks were categorized according to their degree of processing based on the NOVA classification. Unconditional multivariable logistic regression was used to evaluate the association between ultra-processed food and drink consumption and colorectal, breast, and prostate cancer. In multiple adjusted models, consumption of ultra-processed foods and drinks was associated with a higher risk of colorectal cancer (OR for a 10% increase in consumption: 1.11; 95% CI 1.04-1.18). The corresponding odds for breast (OR 1.03; 95% CI 0.96-1.11) and prostate cancer (OR 1.02; 95% CI 0.93-1.12) were indicative of no association. Results of this large population-based case-control study suggest an association between the consumption of ultra-processed foods and drinks and colorectal cancer. Food policy and public health should include a focus on food processing when formulating dietary guidelines.

Identifiants

pubmed: 33743289
pii: S0261-5614(21)00121-7
doi: 10.1016/j.clnu.2021.02.033
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1537-1545

Informations de copyright

Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no competing interests.

Auteurs

Dora Romaguera (D)

Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain; Instituto de Investigación Sanitaria Illes Balears (IdISBa), Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain. Electronic address: dora.romaguera@isglobal.org.

Sílvia Fernández-Barrés (S)

Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain. Electronic address: silvia.fernandez@isglobal.org.

Esther Gracia-Lavedán (E)

Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain. Electronic address: esthergrala@gmail.com.

Eva Vendrell (E)

Faculty of Health Sciences, Universitat Oberta de Catalunya (Open University of Catalonia, UOC), 08018, Barcelona, Spain. Electronic address: evavendrell5@gmail.com.

Mikel Azpiri (M)

Public Health Division of Gipuzkoa, Biodonostia Research Institute, San Sebastian, Spain. Electronic address: koor-tolosa@euskadi.eus.

Emma Ruiz-Moreno (E)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Cancer & Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain. Electronic address: e.ruiz@externos.isciii.es.

Vicente Martín (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; The Research Group in Gene - Environment and Health Interactions (GIIGAS)/Institut of Biomedicine (IBIOMED), Universidad de León, León, Spain; Faculty of Health Sciences, Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, Spain. Electronic address: vicente.martin@unileon.es.

Inés Gómez-Acebo (I)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Universidad de Cantabria - IDIVAL, Santander, Spain. Electronic address: ines.gomez@unican.es.

Mireia Obón (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mobon@iconcologia.net.

Amaia Molinuevo (A)

Public Health Division of Gipuzkoa, Biodonostia Research Institute, San Sebastian, Spain. Electronic address: au-molinuevo@euskadi.eus.

Ujué Fresán (U)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain. Electronic address: ujue.fresan.salvo@navarra.es.

Ana Molina-Barceló (A)

Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain. Electronic address: molina_anabar@gva.es.

Rocío Olmedo-Requena (R)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Granada, Spain; Instituto de Investigación Biosanitaria de Granada ibs.GRANADA, Spain. Electronic address: rocioolmedo@ugr.es.

Adonina Tardón (A)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Medicine, University of Oviedo, Oviedo, Spain. Electronic address: atardon@uniovi.es.

Juan Alguacil (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain. Electronic address: juan.alguacil@dbasp.uhu.es.

Marta Solans (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain. Electronic address: martasolans@gmail.com.

Jose M Huerta (JM)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain. Electronic address: jmhuerta.carm@gmail.com.

José Manuel Ruiz-Dominguez (JM)

Department of Urology, Hospital Germans Trias i Pujol, Badalona, Spain. Electronic address: jmruizdominguez@gmail.com.

Nuria Aragonés (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Epidemiology Section, Public Health Division, Department of Health, Madrid, Spain. Electronic address: nuria.aragones@salud.madrid.org.

Tania Fernández-Villa (T)

The Research Group in Gene - Environment and Health Interactions (GIIGAS)/Institut of Biomedicine (IBIOMED), Universidad de León, León, Spain; Faculty of Health Sciences, Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, Spain. Electronic address: tferv@unileon.es.

Trinidad Dierssen-Sotos (T)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Universidad de Cantabria - IDIVAL, Santander, Spain. Electronic address: dierssent@unican.es.

Victor Moreno (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: v.moreno@iconcologia.net.

Marcela Guevara (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: mp.guevara.eslava@navarra.es.

Mercedes Vanaclocha-Espi (M)

Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain. Electronic address: vanaclocha_mer@gva.es.

Macarena Lozano-Lorca (M)

Department of Preventive Medicine and Public Health, School of Medicine, University of Granada, Spain. Electronic address: macarenalozano@ugr.es.

Guillermo Fernández-Tardón (G)

Department of Medicine, University of Oviedo, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain. Electronic address: gfernanta@gmail.com.

Gemma Castaño-Vinyals (G)

Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Electronic address: gemma.castano@isglobal.org.

Beatriz Pérez-Gómez (B)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Cancer & Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain. Electronic address: bperez@isciii.es.

Antonio J Molina (AJ)

The Research Group in Gene - Environment and Health Interactions (GIIGAS)/Institut of Biomedicine (IBIOMED), Universidad de León, León, Spain; Faculty of Health Sciences, Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, Spain. Electronic address: ajmolt@unileon.es.

Javier Llorca (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Universidad de Cantabria - IDIVAL, Santander, Spain. Electronic address: javier.llorca@unican.es.

Leire Gil (L)

Public Health Division of Gipuzkoa, Biodonostia Research Institute, San Sebastian, Spain. Electronic address: l-gil@euskadi.eus.

Jesús Castilla (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: jcastilc@navarra.es.

Marina Pollán (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Cancer & Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain. Electronic address: mpollan@isciii.es.

Manolis Kogevinas (M)

Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Electronic address: manolis.kogevinas@isglobal.org.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Public Health Division of Gipuzkoa, Biodonostia Research Institute, San Sebastian, Spain. Electronic address: epicss-san@euskadi.eus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH